The Food and Drug Administration Wednesday authorized the emergency use of infusion pumps to counteract insufficient supplies needed for the continuous infusion of medications, total parenteral nutrition and other fluids into COVID-19 patients.

The agency said this includes infusion pumps with remote monitoring or remote manual control features that can help promote safe physical distances to reduce health care providers’ COVID-19 exposure.

FDA also updated its guidance for pharmacy compounders’ use of personal protective equipment.

The guidance, released yesterday, clarifies that intended-sterile drugs can be compounded in segregated compounding areas that are not within cleanrooms, assuming specific beyond-use dates are utilized. The agency said it adopted this policy to help assure patients’ access to necessary medications while reducing the risks of compounding when standard PPE are not available.

Related News Articles

Headline
The COVID-19 pandemic has brought new challenges for health care providers, including the way teams communicate and work together. In this first of a two-part…
Headline
The Food and Drug Administration yesterday issued a reminder to health care facilities’ reprocessing staffs to follow the agency-outlined decontamination cycle…
Headline
The Food and Drug Administration this week authorized the emergency use of certain personal protective equipment to help address insufficient supply due to the…
Headline
The House Education and Labor Committee’s Workforce Protections Subcommittee today held a hearing examining federal actions to protect workers from COVID-19,…
Headline
The Federal Reserve has announced that it is establishing a Main Street Lending Program to support lending to small and medium-sized businesses that were in…
Headline
The Small Business Administration today released an interim final rule to clarify Paycheck Protection Program loan forgiveness requirements, and the agency’s…